| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 08/22/2002 | US20020115691 S-rabeprazole compositions and methods |
| 08/22/2002 | US20020115690 Free of alcohol and propylene glycol; surfactant; polyethylene glycol solvent having a mean molecular weight of greater than 300 but lower than 600 |
| 08/22/2002 | US20020115686 Organic compounds |
| 08/22/2002 | US20020115683 Treatment of anti-depression drug-induced sexual dysfunction with apomorphine |
| 08/22/2002 | US20020115681 Anticholinergics which have a long-lasting effect, such as glycopyrronium bromide, tiotropium bromide or an ester of bi-or tricyclic amino alcohol such as a nortropanol |
| 08/22/2002 | US20020115659 Compounds having heterocyclic groups containing two nitrogen atoms for treating multidrug resistance |
| 08/22/2002 | US20020115645 Stabilized aqueous suspensions for parenteral use |
| 08/22/2002 | US20020115638 Method of forming a barrier on an epidermal surface |
| 08/22/2002 | US20020115622 Therapeutic agent for mastitis of livestock and method for treating mastitis using the same agent |
| 08/22/2002 | US20020115609 Materials and methods for making improved micelle compositions |
| 08/22/2002 | US20020115592 And optionally aprotinin, in a nonaqueous hydrophilic medium of an alcohol and a cosolvent, in association with a medium chain partial glyceride, optionally in admixture a long-chain polyoxyethylene glycol; fine suspension |
| 08/22/2002 | US20020115588 Dry powder of parathyroid hormone suitable for inhalation of specified particle size in diameters; treating osteoporosis |
| 08/22/2002 | US20020115587 Instillation techniques for ophthalmic agents to enhance treatment effect |
| 08/22/2002 | US20020114852 Extract of nerium species, pharmaceutical composition thereof and methods for preparation thereof |
| 08/22/2002 | US20020114849 Topically applied formulation capable of treating subcutaneous tissue comprising an alkali metal hypohalite (AMH); for therapy of microbial infection; arthritis and/or gout; hemorrhoids |
| 08/22/2002 | US20020114844 Particle formation methods and their products |
| 08/22/2002 | US20020114843 Placing the quantity of microparticles into a container; maintaining the microparticles at a conditioning temperature for a period of time |
| 08/22/2002 | US20020114841 Composition and method |
| 08/22/2002 | US20020114839 Fenofibrate pharmaceutical composition having high bioavailability and method for preparing it |
| 08/22/2002 | US20020114838 Uniform drug delivery therapy |
| 08/22/2002 | US20020114837 Galenic composition for low bioavailability medicaments |
| 08/22/2002 | US20020114836 Methods for making sustained-release pharmaceutical compositions of ergot alkaloids having improved bioavailability and compositions thereof |
| 08/22/2002 | US20020114835 Administering at a site biocompatible, biodegradable, biodegradable, controlled release formulation comprising a local anesthetic, being present in a concentration effective to induce a localized condition |
| 08/22/2002 | US20020114834 Method of dispensing a formula with medical or nutritional preparations in the form of initially-reduced-release particles (IRRP) |
| 08/22/2002 | US20020114833 Fast dissolving tablet |
| 08/22/2002 | US20020114832 Pharmaceutical preparation comprising peppermint oil and caraway oil in delayed release form |
| 08/22/2002 | US20020114831 Pharmaceutical formulation |
| 08/22/2002 | US20020114830 Suitable for oral administration comprising oils or oil soluble ingredients useful in the maintenance and/or promotion of health, in capsule form |
| 08/22/2002 | US20020114829 Therapy of autism, multiple sclerosis, eneuresis, Parkinson's disease, amyotrophic lateral sclerosis, brain ischemia, stroke, Cerebral palsy, sleep disorder, feeding disorder and AIDS-associated dementias, using biologically active liposome |
| 08/22/2002 | US20020114828 For facilitating the transfer of nucleic acids into cells; gene therapy; transfection |
| 08/22/2002 | US20020114827 Methods and apparatus for improved administration of analgesics |
| 08/22/2002 | US20020114820 Products for topical applications comprising oil bodies |
| 08/22/2002 | US20020114818 DNA sequence coated onto carrier particle, DNA sequence comprising promoter operative in cells of a mammal and a protein coding region coding for determinant of hantavirus protein |
| 08/22/2002 | US20020114813 Comprising target cell specific portion and enzymatically active portion capable of generating cyanide from a cyanogenic pro-drug; treatment of bladder cancer |
| 08/22/2002 | US20020114803 Compositions and methods for enhancing receptor-mediated cellular internalization |
| 08/22/2002 | US20020114802 Oral immunoglobulin treatment for inflammatory bowel disease |
| 08/22/2002 | US20020114801 Heparanase specific molecular probes and their use in research and medical applications |
| 08/22/2002 | US20020114798 Stable enzymatic wound debrider |
| 08/22/2002 | US20020114796 Wound healing agents comprising fibrinogen, fibrin, thrombin, transglutaminase, and serpin protease inhibitor which doesn not inhibit collagenase and elastase in blood plasma |
| 08/22/2002 | US20020114793 Methods for inducing the differentiation of monocytes into functional dendritic cells and immunotherapeutic compositions including such dendritic cells |
| 08/22/2002 | US20020114782 Stabilized interferon compositions |
| 08/22/2002 | US20020114778 Comprises ethylene oxide-propylene oxide block copolymer providing viscosity and hydroxypropyl methylcellulose improving durability, for moisturizing and lubricating eye drops containing opthalmic drugs |
| 08/22/2002 | US20020114776 Method for the prevention, inhibition, or treatment of vaginitis and/or bacterial vaginosis using polystyrene sulfonate |
| 08/22/2002 | US20020114767 Tablet or a powder forming a mouthwash upon dissolution in water, which contains copper(ll)gluconate and a disintegrant selected from sodium and calcium bicarbonate |
| 08/22/2002 | US20020114766 Milling process for the production of finely milled medicinal substances |
| 08/22/2002 | US20020114763 Inorganic materials for radioactive drug delivery |
| 08/22/2002 | DE10204303A1 Kräuterbad Herbal |
| 08/22/2002 | DE10106024A1 Verfahren zur Herstellung von Dronabinol Process for preparing dronabinol |
| 08/22/2002 | DE10055857A1 Neue pharmazeutische Depotformulierung New pharmaceutical depot formulation |
| 08/22/2002 | CA2666611A1 Novel succinate salt of o-desmethyl-venlafaxine |
| 08/22/2002 | CA2533400A1 Cannabinoids pharmaceutical formulations |
| 08/22/2002 | CA2438707A1 Oral formulations containing mucopolysaccharide for small intestine delivery and their use in the treatment circulatory disorders |
| 08/22/2002 | CA2438641A1 Stabilized pharmaceutical and thyroid hormone compositions and method of preparation |
| 08/22/2002 | CA2437967A1 Novel ophthalmic compositions |
| 08/22/2002 | CA2437890A1 Methods and clinical devices for the inhibition or prevention of mammalian cell growth |
| 08/22/2002 | CA2437870A1 Radiation cross-linked hydrogels |
| 08/22/2002 | CA2437864A1 Methods of preventing ventilator associated pneumonia by oral administration of antimicrobial ib-367 peptides |
| 08/22/2002 | CA2437768A1 Targetted anti-tumor drug delivery systems |
| 08/22/2002 | CA2437731A1 A medicinal composition and use comprising turmeric extract for smoke detoxification |
| 08/22/2002 | CA2437578A1 Carotenoid-loaded liposomes |
| 08/22/2002 | CA2437402A1 New crystal forms of oxcarbazepine and processes for their preparation |
| 08/22/2002 | CA2436452A1 A compound and method of treatment for fungal pathologies of the oral cavity |
| 08/22/2002 | CA2435455A1 Therapeutic agents complexed with calcium phosphate and encased by casein |
| 08/22/2002 | CA2434976A1 Medicament formulation containing a muscarinic agonist |
| 08/22/2002 | CA2434835A1 Novel modified released formulation |
| 08/22/2002 | CA2434641A1 Chemotherapeutic microemulsion compositions of paclitaxel with improved oral bioavailability |
| 08/22/2002 | CA2434542A1 Novel modified release formulation |
| 08/22/2002 | CA2426535A1 Heteroaryl alkyl piperazine derivatives as fatty acid oxidation inhibitors |
| 08/21/2002 | EP1232758A1 Polynucleotide formulated for improved intracellular transfer |
| 08/21/2002 | EP1232756A1 Drugs, drinks or foods |
| 08/21/2002 | EP1232753A1 Protein solution preparation and method of stabilizing the same |
| 08/21/2002 | EP1232752A1 Helium-oxygen mixture with therapeutic application |
| 08/21/2002 | EP1232751A1 Remedies for periodontosis |
| 08/21/2002 | EP1232747A2 Controlled release tablet of bupropion hydrochloride |
| 08/21/2002 | EP1232746A1 Pharmaceutical composition comprising xanthan gum |
| 08/21/2002 | EP1232745A1 Carrier particles for use in dry powder inhalers |
| 08/21/2002 | EP1232264A2 Human fgf-21 gene and gene expression products |
| 08/21/2002 | EP1232262A2 Recombinant gelatin in vaccines |
| 08/21/2002 | EP1232254A1 Process for the production of a reversibly inactive acidified plasmin composition |
| 08/21/2002 | EP1232252A1 Reversibly inactivated acidified plasmin |
| 08/21/2002 | EP1232251A1 Method of thrombolysis by local delivery of reversibly inactivated acidified plasmin |
| 08/21/2002 | EP1232188A1 Cyclodextrins monosubstituted to persubstituted by fluoroalkyl groups, preparation and use thereof |
| 08/21/2002 | EP1232182A2 Animal collagens and gelatins |
| 08/21/2002 | EP1232181A2 Recombinant gelatins |
| 08/21/2002 | EP1232173A1 Fusidic acid derivatives |
| 08/21/2002 | EP1232168A2 Synthetic lipid-a analogs and uses thereof |
| 08/21/2002 | EP1232146A1 4-(4'-hydroxyphenyl)amino-6,7-dimethoxyquinazoline to prevent development of colorectal cancer |
| 08/21/2002 | EP1232100A1 Injection-moulded water-soluble container |
| 08/21/2002 | EP1232002A1 Method for the production of particles |
| 08/21/2002 | EP1231948A1 A propellant free spray-on skin patch composition for improving wound healing and for drug administration |
| 08/21/2002 | EP1231941A1 Tablets comprising micro-organisms and method for preparation of the tablets |
| 08/21/2002 | EP1231940A1 Stable amorphous amifostine composition, and preparation thereof |
| 08/21/2002 | EP1231936A2 Methods and compositions for treatment of keratoconus using protease inhibitors |
| 08/21/2002 | EP1231933A1 An aqueous solution formulation of alpha-interferon |
| 08/21/2002 | EP1231927A2 Nontoxic vernix compositions and method of producing |
| 08/21/2002 | EP1231926A2 New complex, and methods for its production and use |
| 08/21/2002 | EP1231924A2 Treatment of systemic lupus erythematosus (sle) with dehydroepiandrosterone |
| 08/21/2002 | EP1231920A1 Solutions containing epinastine |
| 08/21/2002 | EP1231918A2 Novel composition based on a thiazolidinedione and metformin and use |
| 08/21/2002 | EP1231917A2 Pharmaceutical composition comprising a thiazolidinedione-metformin hydrochloride |